Close Menu

Trovagene

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Trovagene today said it has completed its acquisition of the CLIA laboratory of MultiGen Diagnostics.

TrovaGene said this week that it has obtained an exclusive worldwide license for mutations of the SF3B1 splicing factor that are associated with disease progression and chemotherapy response in chronic lymphocytic leukemia.

PrimeraDx this week announced that it has appointed Leroy Hood to its scientific advisory board.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – TrovaGene today said that it has licensed exclusive worldwide rights to assay technology for the detection of hairy cell leukemia.

By Monica Heger
This story, originally published Aug. 11, has been updated to include comments from TrovaGene co-founder Gabriele Cerrone.

Canon, Philipps-Universität Marburg, Johns Hopkins University, Brandeis University, Samsung, City of Hope, Amplion, and Trovagene are awarded US patents.

US patents awarded to LLNL, TrovaGene, Rockefeller U, Gen-Probe, Human Genetic Signatures, Riken, DNAForm, U of Utah, Idaho Tech, Rubicon, Cepheid, Toshiba, Chang Gung University, Samsung, Apodemus, and Robert-Koch Institut.

Pages

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.